Kazia Therapeutics (KZIA) Receivables - Other (2017 - 2025)

Kazia Therapeutics (KZIA) has 8 years of Receivables - Other data on file, last reported at $202128.1 in Q4 2025.

• In Q4 2025, Receivables - Other changed N/A year-over-year to $202128.1; the TTM figure through Dec 2025 stood at $202128.1 (changed N/A YoY), while the FY2025 annual figure was $57782.4, down 34.08% from the prior year.
• Receivables - Other rose to $202128.1 in Q4 2025, from $57782.4 in the prior quarter.
• Across five years, Receivables - Other topped out at $202128.1 in Q4 2025 and bottomed at $26039.6 in Q4 2023.
• A 5-year average of $75755.0 and a median of $58524.2 in 2021 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other plunged 51.04% — and 2023, when it jumped 142.61%.
• Year by year, Receivables - Other stood at $58524.2 in 2021, then plunged by 51.04% to $28650.7 in 2022, then declined by 9.11% to $26039.6 in 2023, then surged by 236.6% to $87650.3 in 2024, then soared by 130.61% to $202128.1 in 2025.
• The last three Receivables - Other figures came in at $202128.1 (Q4 2025), $57782.4 (Q2 2025), and $87650.3 (Q2 2024), per Business Quant data.

Peer Comparison